|
CDC Field Epi Manual
|
|
0
|
551
|
February 10, 2019
|
|
COVID-19 diagnostics—not at the expense of other diseases
|
|
0
|
549
|
June 8, 2020
|
|
99DOTS: A Low-Cost Approach to Monitoring and Improving Medication Adherence
|
|
1
|
388
|
February 5, 2019
|
|
TB laboratory manuals issued to support the implementation of WHO-recommended diagnostics
|
|
0
|
546
|
May 13, 2022
|
|
Free eBook: Quality of Tuberculosis Care
|
|
0
|
546
|
March 29, 2021
|
|
Diagnostic infectious diseases testing outside clinics: A global systematic review and meta-analysis
|
|
0
|
546
|
August 22, 2020
|
|
Healthy Worship despite COVID-19: Public health recommendations on the resumption of religious activities by the communities of faith
|
|
0
|
546
|
June 18, 2020
|
|
Fleming Fund Phase I report now available
|
|
0
|
545
|
April 27, 2022
|
|
Fast coronavirus tests: what they can and can’t do
|
|
0
|
544
|
September 22, 2020
|
|
Call for applications for the third EDL
|
|
0
|
541
|
August 12, 2019
|
|
Global Frugal Diagnostics Network Second Virtual Meet and Greet - Aug. 30
|
|
0
|
540
|
August 12, 2023
|
|
Frugal Innovations in Global Health Conference
|
|
0
|
538
|
February 15, 2022
|
|
Mobile Devices and Health
|
|
0
|
538
|
September 5, 2019
|
|
The silent and dangerous inequity around access to COVID-19 testing: A call to action
|
|
0
|
537
|
December 14, 2021
|
|
Availability of essential diagnostics in primary care in India
|
|
0
|
536
|
November 28, 2018
|
|
Scouting for Tuberculosis Innovations
|
|
0
|
535
|
August 19, 2019
|
|
Open Letter to Cepheid - For Endorsement - Time to Lower the Price of Xpert Cartridges to US$ 5
|
|
0
|
534
|
October 15, 2019
|
|
Use of alternative interferon-gamma release assays for the diagnosis of TB infection - WHO Policy Statement
|
|
0
|
533
|
January 28, 2022
|
|
Essential Diagnostics: A Key Element of Universal Health Coverage
|
|
0
|
532
|
April 30, 2019
|
|
Funding opportunity: Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB)
|
|
0
|
532
|
April 15, 2019
|
|
Advanced TB Research Training Course
|
|
0
|
531
|
July 26, 2023
|
|
Making cough count in tuberculosis care
|
|
0
|
530
|
July 8, 2022
|
|
Tuberculosis detection from chest x-rays for triaging in a high tuberculosis-burden setting: an evaluation of five artificial intelligence algorithms
|
|
0
|
528
|
August 24, 2021
|
|
Malaria-LAMP molecular test
|
|
0
|
528
|
April 24, 2019
|
|
Ensuring continuity of tuberculosis care during the covid-19 crisis
|
|
0
|
527
|
June 25, 2020
|
|
Diagnostic preparedness for WHO Blueprint pathogens
|
|
0
|
527
|
March 6, 2019
|
|
Xpert XDR Launch
|
|
0
|
525
|
July 16, 2020
|
|
Portable kit to treat babies with jaundice goes on trial in Peru
|
|
0
|
525
|
April 16, 2019
|
|
Please sign this call! Montreal Declaration on Clinical Bacteriology Diagnostics for Antimicrobial Resistance
|
|
0
|
524
|
January 24, 2020
|
|
Faster, better, cheaper: the rise of CRISPR in disease detection
|
|
0
|
524
|
February 20, 2019
|
|
WHO announces updates on new molecular assays for the diagnosis of tuberculosis
|
|
0
|
522
|
February 17, 2021
|
|
Demand for coronavirus tests raises concerns over HIV and malaria
|
|
0
|
522
|
May 1, 2020
|
|
India’s COVID-19 Testing Capacity Must Grow by a Factor of 10: Here’s How That Can Happen
|
|
0
|
521
|
June 7, 2020
|
|
Evaluation of the Xpert MTB Host Response assay for the triage of patient
|
|
1
|
207
|
July 26, 2024
|
|
Global Fund and Unitaid are inviting manufacturers of diagnostics to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD)
|
|
0
|
520
|
October 3, 2019
|
|
Effect of Prices, Distribution Strategies, and Marketing on Demand for HIV Self-testing in Zimbabwe:A Randomized Clinical Trial
|
|
0
|
520
|
September 3, 2019
|
|
Special issue of Lab Culture on POC Technologies
|
|
0
|
520
|
August 27, 2019
|
|
Archives of Failures in Global Health
|
|
0
|
520
|
July 29, 2019
|
|
Lay testing cadres and point-of-care diagnostic tests for HIV and other diseases
|
|
0
|
519
|
December 12, 2021
|
|
COVID-19 Diagnostics and Testing: online course
|
|
0
|
515
|
April 8, 2020
|
|
Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis
|
|
0
|
514
|
December 28, 2021
|
|
Covidization of research
|
|
0
|
514
|
July 27, 2020
|
|
Friday 26 Nov: MSF webinar on diagnostics manufacturing in Africa
|
|
0
|
513
|
November 23, 2021
|
|
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views
|
|
0
|
511
|
April 27, 2022
|
|
Technical Report on critical concentrations for drug susceptibility testing of isoniazid and the rifamycins (rifampicin, rifabutin and rifapentine)
|
|
0
|
511
|
February 9, 2021
|
|
Ten Principles for Access to Multi-disease Molecular Diagnostics: A Global Call to Action
|
|
0
|
510
|
August 23, 2022
|
|
No Time to Wait: Securing the future from drug-resistant infections
|
|
0
|
509
|
April 30, 2019
|
|
Job: TB Programme Scientist at FIND
|
|
0
|
508
|
January 27, 2022
|
|
Two funded PhD positions in Tuberculosis Diagnostics.
|
|
0
|
508
|
August 26, 2020
|
|
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|
|
0
|
507
|
June 5, 2020
|